United States · FDA National Drug Code directory
Heparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-400_fdb63b38-4359-4943-a931-e4603c1fbab8
- Product NDC
- 25021-400
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Heparin Sodium
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100706
- Source listing expiry
- 20271231
Source-listed ingredients
- HEPARIN SODIUM — 1000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (25021-400-01) / 1 mL in 1 VIAL · 25021-400-01
- 25 VIAL in 1 CARTON (25021-400-10) / 10 mL in 1 VIAL · 25021-400-10
- 25 VIAL in 1 CARTON (25021-400-30) / 30 mL in 1 VIAL · 25021-400-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →